PDS Biotechnology Corp
PDSB· Nasdaq
Filed Mar 2, 2017 · 10-K · 61 days after period end · 0001140361-17-010287
| Metric | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|
| Net Income | -$9.52M | -$7.96M | -$3.16M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 2, 2017 · 61 d after period end